HomeENVB • NASDAQ
add
Enveric Biosciences Inc
Previous close
$1.28
Day range
$1.21 - $1.35
Year range
$1.01 - $14.18
Market cap
3.21M USD
Avg Volume
55.53K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.19M | -11.70% |
Net income | -2.18M | 11.07% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.11M | 11.93% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.29M | -32.44% |
Total assets | 5.10M | -42.35% |
Total liabilities | 1.18M | -49.98% |
Total equity | 3.92M | — |
Shares outstanding | 1.80M | — |
Price to book | 0.59 | — |
Return on assets | -133.64% | — |
Return on capital | -198.49% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -2.18M | 11.07% |
Cash from operations | -2.39M | 7.96% |
Cash from investing | — | — |
Cash from financing | 4.45M | -33.18% |
Net change in cash | 2.05M | -49.52% |
Free cash flow | -1.64M | 1.67% |
About
Founded
1994
Headquarters
Website
Employees
6
